image
Opening
a new frontier
in pharmacology
Opening a new frontier
in pharmacology
Opening
a new frontier
in pharmacology
A pipeline of breakthrough
pharmacological inhibitors
Signaling Specific inhibitors
of the CB1 (CB1-SSi)
Targeting diseases while protecting physiology
AEF0117 for cannabis-related disorders
AEF0217 for the treatment of cognitive deficits
Aelis Farma’s Mission
Conjugate the scientific breakthrough of CB1-SSi with innovative drug development to provide new specific and safe treatments for CNS diseases with unmet medical needs.
Pier Vincenzo Piazza, CEO
Latest News
Aelis Farma CEO speaks at ATHS conference in Biarritz
October 2021
+
Pier Vincenzo Piazza, CEO of Aelis Farma gives Opening Keynote speech at the 3rd edition of the Healthtech Congress
October 2021
+